文献速递肥胖与代谢综合征骨质疏松与钙磷/甲状旁腺

GIPR基因的肥胖相关变异与骨折风险或骨密度无关

Obesity Variants in the GIPR Gene Are not Associated With Risk of Fracture or Bone Mineral Density.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

结果显示这些变异与骨折风险增加或骨密度降低均无显著关联。

要点

  • GIPR的3个错义变异与骨折风险增加或骨密度降低均无显著关联。
  • GIPR功能丧失变异负荷与临床验证DXA测量的骨密度及骨折均无关,但与跟骨超声估算骨密度相关。
  • 结果提示拮抗GIPR治疗肥胖可能不增加骨折风险或降低骨密度。

核心结论

  • GIPR的错义变异或功能丧失变异负荷与骨折风险或骨密度降低无关。

主要发现

  • GIPR的3个错义变异均与骨折风险增加或骨密度降低无显著关联。
  • GIPR功能丧失变异负荷与骨折及临床验证DXA测量的骨密度无关,但与跟骨超声估算骨密度相关。

关键数值与推荐

  • 评估的骨折部位包括一般人群的任何骨折、髋部骨折、椎体骨折和前臂骨折,以及绝经后女性的非椎体骨折和骨质疏松性骨折。
  • 骨密度评估部位包括DXA测量的腰椎、股骨颈和全身骨密度,以及跟骨超声估算骨密度(eBMD)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: It is not clear if antagonizing the GIP (glucose-dependent insulinotropic polypeptide) receptor (GIPR) for treatment of obesity is likely to increase the risk of fractures, or to lower bone mineral density (BMD) beyond what is expected with rapid weight loss. OBJECTIVE: The objective of this study was to investigate the risk of fracture and BMD of sequence variants in GIPR that reduce the activity of the GIP receptor and have been associated with reduced body mass index (BMI). METHODS: We analyzed the association of 3 missense variants in GIPR, a common variant, rs1800437 (p.Glu354Gln), and 2 rare variants, rs139215588 (p.Arg190Gln) and rs143430880 (p.Glu288Gly), as well as a burden of predicted loss-of-function (LoF) variants with risk of fracture and with BMD in a large meta-analysis of up to 1.2 million participants. We analyzed associations with fractures at different skeletal sites in the general population: any fractures, hip fractures, vertebral fractures and forearm fractures, and specifically nonvertebral and osteoporotic fractures in postmenopausal women. We also evaluated associations with BMD at the lumbar spine, femoral neck, and total body measured with dual-energy x-ray absorptiometry (DXA), and with BMD estimated from heel ultrasound (eBMD). RESULTS: None of the 3 missense variants in GIPR was significantly associated with increased risk of fractures or with lower BMD. Burden of LoF variants in GIPR was not associated with fractures or with BMD measured with clinically validated DXA, but was associated with eBMD. CONCLUSION: Missense variants in GIPR, or burden of LoF variants in the gene, are not associated with risk of fractures or with lower BMD.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Styrkarsdottir U, Tragante V, Stefansdottir L, et al. Obesity Variants in the GIPR Gene Are not Associated With Risk of Fracture or Bone Mineral Density. J Clin Endocrinol Metab. 2024. PMID: 38118020. doi:10.1210/clinem/dgad734

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。